Clinical Outcomes in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices
Canadian Journal of Cardiology · 2025
DOI: 10.1016/j.cjca.2024.12.007 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Siddhartha Mengi und 40 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart & Lung Institute, Laval University, Québec City, Québec, Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fundación Alfonso Martín Escudero.
Abstract (Originalsprache)
BACKGROUND: Atrial fibrillation (AF) has been identified as a marker of advanced cardiac damage in patients with aortic stenosis. However, the factors associated with poorer outcomes among AF patients in contemporary transcatheter aortic valve replacement (TAVR) practice, particularly regarding mortality and heart failure (HF)-related hospitalizations, remain largely unknown. METHODS: In this multicenter study, we assessed consecutive patients with a history of AF and evaluated the clinical outcomes of those who underwent TAVR with newer generation devices using either balloon- or self-expandable valves. RESULTS: A total of 3476 patients were included in the study. After a median follow-up of 2 (interquartile range, 1-4) years, 36.1% patients had died, with 51.5% of deaths being cardiovascular-related, including 15.6% from HF. HF-related hospitalizations post-TAVR accounted for 34.8% of all hospitalizations and were associated with a higher mortality risk (hazard ratio [HR], 1.54; 95% confidence interval [CI], 1.32-1.81; P < 0.001). Permanent AF was identified as an independent predictor of all-cause mortality or HF-related hospitalizations (HR, 1.25; 95% CI, 1.10-1.40; P < 0.001), as did other baseline characteristics, including chronic kidney disease (HR, 1.23; 95% CI, 1.09-1.38; P = 0.001), anemia (HR, 1.21; 95% CI, 1.07-1.36; P = 0.002), and New York Heart Association functional class III or IV (HR, 1.13; 95% CI, 1.01-1.27; P = 0.045). In addition, early postprocedural complications, including stroke and bleeding, also significantly increased the risk of mortality (HR, 5.52; 95% CI, 3.12-9.79; P < 0.001) and HF-related hospitalizations (HR, 1.17; 95% CI, 1.03-1.33; P = 0.014). CONCLUSIONS: AF patients exhibited a high risk of mortality and HF-related hospitalizations in a contemporary TAVR cohort. Several baseline comorbidities and periprocedural complications, along with permanent (vs paroxysmal) AF, were associated with poorer outcomes. These findings confirm the negative impact of AF despite the continued improvements in TAVR technology and underscore the importance of early intervention and optimization of HF management to improve outcomes in this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Quebec Heart & Lung Institute, Laval University, Québec City, Québec, Canada.
- Unité Médico-Chirurgicale des Valvulopathies, Hôpital Haut-Leveque, CHU Bordeaux, Pessac, France.
- Department of Cardiology, Hospital Bichat Claude-Bernard, Paris, France.
- Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Southlake Regional Health Centre, Newmarket, Ontario, Canada.
- Cardiology Department, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.
Förderung
- Fundación Alfonso Martín Escudero
Zitieren
APA
Mengi, S., Cepas-Guillén, P., Ternacle, J., Urena, M., Alperi, A., Cheema, A. N., Veiga-Fernandez, G., Nombela-Franco, L., Vilalta, V., Esposito, G., Campelo-Parada, F., Indolfi, C., Del Trigo, M., Muñoz-Garcia, A., Maneiro, N., Asmarats, L., Regueiro, A., Del Val, D., Serra, V., …, & Rodés-Cabau, J. (2025). Clinical Outcomes in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2024.12.007
Vancouver
Mengi S, Cepas-Guillén P, Ternacle J, Urena M, Alperi A, Cheema AN, et al. Clinical Outcomes in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2024.12.007
BibTeX
@article{Mengi2025,
author = {Mengi, Siddhartha and Cepas-Guillén, Pedro and Ternacle, Julien and Urena, Marina and Alperi, Alberto and Cheema, Asim N and Veiga-Fernandez, Gabriela and Nombela-Franco, Luis and Vilalta, Victoria and Esposito, Giovanni and Campelo-Parada, Francisco and Indolfi, Ciro and Del Trigo, Maria and Muñoz-Garcia, Antonio and Maneiro, Nicolas and Asmarats, Lluís and Regueiro, Ander and Del Val, David and Serra, Vicenç and Auffret, Vincent and Leroux, Lionel and Modine, Thomas and Mesnier, Jules and Suc, Gaspard and Avanzas, Pablo and Rezaei, Effat and Fradejas-Sastre, Victor and Tirado-Conte, Gabriela and Fernández-Nofrerias, Eduard and Angellotti, Domenico and Guitteny, Thibaut and Sorrentino, Sabato and Oteo, Juan Francisco and Díez-Delhoyo, Felipe and Gutiérrez-Alonso, Lola and Vidal-Calés, Pablo and Alfonso, Fernando and Monastyrski, Andrea and Nolf, Maxime and Avvedimento, Marisa and Rodés-Cabau, Josep},
title = {Clinical Outcomes in Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices},
journal = {Canadian Journal of Cardiology},
year = {2025},
doi = {10.1016/j.cjca.2024.12.007}
}
EUVIMED